138 related articles for article (PubMed ID: 20582435)
1. Involvement of PTEN/Akt signaling in capsular invasive carcinomas developed in a rat two-stage thyroid carcinogenesis model after promotion with sulfadimethoxine.
Kemmochi S; Fujimoto H; Woo GH; Inoue K; Takahashi M; Mitsumori K; Hirose M; Nishikawa A; Shibutani M
J Cancer Res Clin Oncol; 2011 Apr; 137(4):723-32. PubMed ID: 20582435
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of calcitriol on the development of capsular invasive carcinomas in a rat two-stage thyroid carcinogenesis model.
Kemmochi S; Fujimoto H; Woo GH; Hirose M; Nishikawa A; Mitsumori K; Shibutani M
J Vet Med Sci; 2011 May; 73(5):655-64. PubMed ID: 21206174
[TBL] [Abstract][Full Text] [Related]
3. Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation.
Imai T; Onose J; Hasumura M; Ueda M; Takizawa T; Hirose M
Toxicol Pathol; 2004; 32(2):229-36. PubMed ID: 15200161
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of aminoguanidine on thyroid follicular carcinoma development in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation.
Imai T; Hasumura M; Cho YM; Ota Y; Takami S; Hirose M; Nishikawa A
Cancer Sci; 2009 Oct; 100(10):1794-800. PubMed ID: 19572977
[TBL] [Abstract][Full Text] [Related]
5. Promoting effects of carminic acid-enriched cochineal extracts on capsular invasive thyroid carcinomas through targeting activation of angiogenesis in rats.
Kemmochi S; Shimamoto K; Shiraki A; Onda N; Hasumi K; Suzuki K; Mitsumori K; Shibutani M
J Toxicol Sci; 2012; 37(3):475-82. PubMed ID: 22687987
[TBL] [Abstract][Full Text] [Related]
6. Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats.
Imai T; Hasumura M; Cho YM; Onose J; Hirose M
Cancer Sci; 2007 Mar; 98(3):294-8. PubMed ID: 17270018
[TBL] [Abstract][Full Text] [Related]
7. Lac color inhibits development of rat thyroid carcinomas through targeting activation of plasma hyaluronan-binding protein.
Kemmochi S; Yamamichi S; Shimamoto K; Onda N; Hasumi K; Suzuki K; Mitsumori K; Shibutani M
Exp Biol Med (Maywood); 2012 Jun; 237(6):728-38. PubMed ID: 22715430
[TBL] [Abstract][Full Text] [Related]
8. Direct progression of capsular invasive carcinomas from subcapsular focal hyperplasias induced by hypothyroidism-mediated tumor promotion in a rat two-stage thyroid carcinogenesis model.
Ago K; Kemmochi S; Morita R; Yafune A; Shiraki A; Mitsumori K; Shibutani M
J Cancer Res Clin Oncol; 2013 Mar; 139(3):395-401. PubMed ID: 23114882
[TBL] [Abstract][Full Text] [Related]
9. Development of invasive follicular cell carcinomas in a rat thyroid carcinogenesis model: biological impact of capsular inflammation and reduced cyclooxygenase-2 expression.
Imai T; Hasumura M; Onose J; Ueda M; Takizawa T; Cho YM; Hirose M
Cancer Sci; 2005 Jan; 96(1):31-7. PubMed ID: 15649252
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
RamÃrez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine.
Ota Y; Imai T; Hasumura M; Cho YM; Takami S; Oyamada T; Hirose M; Nishikawa A; Ogawa K
Toxicol Sci; 2012 Jun; 127(2):339-47. PubMed ID: 22387750
[TBL] [Abstract][Full Text] [Related]
13. Cellular distributions of molecules with altered expression specific to thyroid proliferative lesions developing in a rat thyroid carcinogenesis model.
Woo GH; Takahashi M; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A; Shibutani M
Cancer Sci; 2009 Apr; 100(4):617-25. PubMed ID: 19298605
[TBL] [Abstract][Full Text] [Related]
14. Specificity of co-promoting effects of caffeine on thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.
Son HY; Nishikawa A; Okazaki K; Kitamura Y; Kanki K; Lee KY; Umemura T; Hirose M
Toxicol Pathol; 2004; 32(3):338-44. PubMed ID: 15204976
[TBL] [Abstract][Full Text] [Related]
15. Involvement of glycogen synthase kinase-3beta signaling and aberrant nucleocytoplasmic localization of retinoblastoma protein in tumor promotion in a rat two-stage thyroid carcinogenesis model.
Ago K; Saegusa Y; Nishimura J; Dewa Y; Kemmochi S; Kawai M; Harada T; Mitsumori K; Shibutani M
Exp Toxicol Pathol; 2010 May; 62(3):269-80. PubMed ID: 19505811
[TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
Nozhat Z; Hedayati M
Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
[TBL] [Abstract][Full Text] [Related]
17. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats.
Takagi H; Mitsumori K; Onodera H; Nasu M; Tamura T; Yasuhara K; Takegawa K; Hirose M
Cancer Lett; 2002 Apr; 178(1):1-9. PubMed ID: 11849735
[TBL] [Abstract][Full Text] [Related]
18. The Akt pathway in human breast cancer: a tissue-array-based analysis.
Bose S; Chandran S; Mirocha JM; Bose N
Mod Pathol; 2006 Feb; 19(2):238-45. PubMed ID: 16341149
[TBL] [Abstract][Full Text] [Related]
19. The effect Akt2 deletion on tumor development in Pten(+/-) mice.
Xu PZ; Chen ML; Jeon SM; Peng XD; Hay N
Oncogene; 2012 Jan; 31(4):518-26. PubMed ID: 21743498
[TBL] [Abstract][Full Text] [Related]
20. Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN).
Son HY; Nishikawa A; Ikeda T; Nakamura H; Miyauchi M; Imazawa T; Furukawa F; Hirose M
Jpn J Cancer Res; 2000 Sep; 91(9):899-905. PubMed ID: 11011117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
